Skip to content

Mental Fatigue, Attentional Focus, and Countermovement Jump Performance

The Effects of Acute Mental Fatigue and Attentional Focus Instructions on Countermovement Jump Performance

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07779304
Enrollment
32
Registered
2026-08-21
Start date
2026-09-01
Completion date
2026-11-01
Last updated
2026-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Athletic Performance, Mental Fatigue

Keywords

Countermovement Jump, Attentional Focus, Stroop Task, Crossover Design, Vertical Jump Performance, Cognitive Fatigue

Brief summary

This study examines whether short-term mental fatigue and different jump instructions affect how high people can jump. Thirty-two physically active university students will complete two testing sessions in random order: one after a 30-minute mentally tiring computer task and one after a 30-minute relaxing video. In both sessions, participants will perform vertical jumps while receiving one of three types of instructions: no special instruction, focusing on their own body movements, or focusing on pushing the ground away. The study will compare jump height across these conditions to better understand how mental tiredness and coaching cues affect jumping performance, which may help coaches and athletes design better training and competition preparation.

Detailed description

This study uses a sex-stratified, randomized, counterbalanced crossover design with repeated measures to examine the effects of acute mental fatigue and attentional-focus instructions on countermovement jump (CMJ) performance. Thirty-two physically active undergraduate students (16 women, 16 men), aged 18-30 years, will be enrolled from the Faculty of Sport Sciences at İnönü University, Malatya, Türkiye. Each participant will complete two experimental protocols, separated by at least 72 hours: a control protocol (approximately 30 minutes of passive viewing of a narration-free nature video) and a mental-fatigue protocol (a 30-minute computerized color-word Stroop interference task). Protocol order will be randomized and stratified by sex. In both protocols, participants will perform CMJs under three attentional-focus conditions, presented in a randomized order that is held constant within each participant across sessions: no prescribed focus, internal focus (attention directed to the participant's own body movements), and external focus (attention directed to the effect of movement on the environment). CMJ height will be recorded in centimeters using a validated video-based jump-analysis application (My Jump Lab) on a tablet camera recording at 240 frames per second, with the higher of two valid trials retained as the primary outcome for each protocol-by-focus condition. Subjective mental fatigue will be assessed immediately before and after each protocol using a 0-10 visual analogue scale to confirm the effectiveness of the fatigue manipulation. Stroop task performance (total trials, accuracy) and adherence to the assigned attentional-focus instructions will be recorded as secondary measures. The primary analysis will use a 2 (protocol: control, mental fatigue) x 3 (focus: no prescribed, internal, external) x 2 (sex: women, men) mixed-model ANOVA on CMJ height, with protocol and focus as within-participant factors and sex as a between-participant factor. Reporting will follow CONSORT 2025 and the CONSORT extension for randomized crossover trials.

Interventions

BEHAVIORALMental-Fatigue Protocol (Stroop Task)

A 30-minute computerized color-word Stroop interference task delivered as one uninterrupted block on a custom program, in which participants identify the font color of color-word stimuli while ignoring word meaning, inducing acute mental fatigue prior to countermovement jump testing.

BEHAVIORALControl Protocol (Nature Video)

Approximately 30 minutes of passive viewing of a narration-free nature video under standardized lighting, seating, and sound conditions, serving as the non-fatiguing control condition matched in duration to the mental-fatigue protocol.

BEHAVIORALNo Prescribed Focus Instruction

A verbal cue delivered before each jump attempt with no directional attentional instruction: "When you are ready, jump as high as possible."

BEHAVIORALInternal Focus Instruction

A verbal cue delivered before each jump attempt directing attention to the participant's own body movements: "When you are ready, focus on extending your knees and hips as quickly and explosively as possible while jumping as high as possible."

BEHAVIORALExternal Focus Instruction

A verbal cue delivered before each jump attempt directing attention to the effect of movement on the environment: "When you are ready, focus on pushing the ground away from you as quickly and explosively as possible while jumping as high as possible."

Sponsors

Inonu University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

Each participant completed both the control and mental-fatigue protocols in a counterbalanced order (crossover). Within each protocol, participants performed countermovement jumps under three attentional-focus conditions (no prescribed focus, internal focus, external focus), presented in one of six randomized orders held constant for each participant across both sessions.

Eligibility

Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 18-30 years * Third- or fourth-year undergraduate student in the Faculty of Sport Sciences, İnönü University * Engaged in structured physical activity on at least 2 days per week * Normal or corrected-to-normal vision and normal color vision * Able to safely perform maximal vertical jumps

Exclusion criteria

* Major lower-extremity surgery or injury * Musculoskeletal injury during the preceding 6 months that could affect jumping * Diagnosed neurological, psychiatric, or cardiovascular disorder * Regular use of medication that could influence alertness, fatigue, cardiovascular responses, or neuromuscular performance * Any health condition compromising safety or measurement validity

Design outcomes

Primary

MeasureTime frameDescription
Countermovement Jump HeightAssessed once per attentional-focus condition (higher of two valid trials) approximately 30 seconds after completion of each 30-minute protocol (control or mental fatigue), across two sessions separated by at least 72 hours.Vertical jump height, measured in centimeters, recorded using a validated video-based jump-analysis application (My Jump Lab) at 240 frames per second. The higher of two valid trials in each protocol-by-attentional-focus condition (control vs. mental fatigue x no prescribed focus, internal focus, external focus) will be retained as the outcome value for that condition.

Secondary

MeasureTime frameDescription
Subjective Mental Fatigue RatingImmediately before and immediately after each 30-minute protocol (control and mental fatigue), across two experimental sessions separated by at least 72 hours.Self-reported mental fatigue rated on a 0-10 visual analogue scale, in response to "How mentally fatigued do you feel right now?" (0 = not mentally fatigued at all, 10 = the highest possible level of mental fatigue).
Stroop Task PerformanceContinuously recorded throughout the 30-minute mental-fatigue protocol, administered in one of the two experimental sessions per participant (protocol order randomized).Total trials completed, number of correct and incorrect responses, and accuracy (%), recorded automatically by the Stroop task software during the mental-fatigue protocol.
Focus-Instruction AdherenceAssessed once per attentional-focus condition, immediately after completion of each 30-minute protocol (control or mental fatigue), across two experimental sessions separated by at least 72 hours.Self-reported adherence to the assigned attentional-focus instructions, rated on a 0-10 visual analogue scale.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 22, 2026